Company Filing History:
6 out of 60 
1 out of 1,036 
Years Active: 2022-2025
Title: The Innovative Contributions of Jay Evans
Introduction
Jay Evans is a notable inventor based in Corvallis, Montana, who has made significant contributions to the field of biomedical research. With a total of five patents to his name, Evans has focused on developing compounds that have the potential to enhance vaccine efficacy and modulate immune responses.
Latest Patents
Among his latest patents, Evans has developed diaryl trehalose compounds and methods of use, particularly as vaccine adjuvants. These compounds are designed to improve the effectiveness of vaccines by enhancing the immune response. Additionally, he has patented lipidated oxoadenines that serve as TLR7/8 receptor ligands, which are useful for modulating immune responses. These innovative compounds may have therapeutic applications in treating cancer, infectious diseases, allergies, and autoimmune disorders.
Career Highlights
Throughout his career, Jay Evans has worked with esteemed institutions such as the University of Montana and Children's Medical Center Corporation. His work in these organizations has allowed him to collaborate on various research projects aimed at advancing medical science and improving patient outcomes.
Collaborations
Evans has collaborated with several notable individuals in his field, including David Burkhart and Kendal T. Ryter. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and discovery.
Conclusion
Jay Evans is a distinguished inventor